Review

Modulation of p38 MAPK signaling in spinal cord injury by curcumin: targeting inflammation, oxidative stress, and apoptosis.

Shokoufeh Rahmani Arman Gholami Abroumand S. Davlatov Fatemeh Mortazavi Moghadam N. V. Kolaeva Fatemeh Tahmasebi H. Babaloo Madjidova Yakutkhon K. Rakhmanov

Sep 2026 · InflammoPharmacology · 0 citations · 146 references

Medicine

TL;DR

Overall, curcumin appears to be a promising adjunctive candidate for limiting secondary injury after SCI, but further mechanistic clarification and improved delivery strategies will be required to enhance translational relevance and support future clinical application.

DOI PubMed Semantic Scholar

View source

Similar papers

Review Open access Sep 2026

IL-33/ST2 Signaling and Microglial Functional-State Transitions After Spinal Cord Injury: Direct Evidence and Mechanistic Hypotheses

Spinal cord injury (SCI) triggers a complex and evolving cascade of pathological events in which neuroinflammation and microenvironmental imbalance critically constrain repair. Among the cellular mediators, microglia exhibit remarkable functional plasticity, transitioning across diverse states that can either support t...

Zi-Yue Ma, Zi-Cheng Lu, Zi-Peng Zhou et al. · International Journal of Mol... · 0 citations

Review Open access Oct 2026

Caspase-1 and Inflammasome Signaling in Spinal Cord Injury: Mechanistic Insights and Translational Gaps

Caspase-1 is a central mediator of canonical inflammasome signaling and drives neuroinflammatory injury through interleukin-1β (IL-1β) and interleukin-18 (IL-18) maturation, gasdermin D (GSDMD)-mediated pyroptosis, and secondary inflammatory cascades. In spinal cord injury (SCI) and other neurologic disorders, experime...

Adonicah Y. Cummings, Adham M. Khalafallah, Bhavjeet S. Sanghera et al. · International Journal of Mol... · 0 citations

Oct 2026

Ergothioneine promotes functional recovery after spinal cord injury by stabilizing VPS35 to suppress mitochondrial damage-driven neuroinflammation and oxidative stress.

BACKGROUND Spinal cord injury (SCI) triggers a complex secondary injury cascade involving neuroinflammation, oxidative stress, and mitochondrial dysfunction. These interconnected pathological processes exacerbate neuronal damage and hinder functional recovery. However, effective therapeutic strategies targeting these i...

Jian Zhou, Chao-Qiang Zhang, Ya-Nan Zhang et al. · Free Radical Biology & Medic... · 0 citations

Review Open access Sep 2026

Tetramethylpyrazine modulates the Nrf2/JNK axis to intervene in ferroptosis and neuroinflammation after spinal cord injury: an integrated perspective from antioxidant to regenerative therapy

The interplay between ferroptosis and neuroinflammation during secondary injury after spinal cord injury (SCI) critically drives permanent neurological dysfunction. Targeting both processes simultaneously is a promising therapeutic strategy. Tetramethylpyrazine (TMP), the main active component of Ligusticum chuanxiong,...

Jia-Hao Dong, Zi-Rui Zhang, Tao Chen · Molecular Biology Reports · 0 citations

Open access Sep 2026

Tamoxifen Modulates Spinal Cord Injury Repair Via CCL2/CCR2 Axis and its Mechanisms

Spinal cord injury (SCI) represents a profoundly serious neurological disorder characterized by limited self-repair capabilities and accompanied by secondary inflammatory damage, rendering its treatment a pressing challenge in the field of medical science research. During the acute phase of SCI, the expression levels o...

Xiang-Zi Wang, Xiao-Quan Liang, Yu-Qi Lin et al. · Journal of Neuroimmune Pharm... · 0 citations

Oct 2026

Paeonol alleviates oxidative stress and brain injury in hypoxic-ischemic encephalopathy by activating the PI3K/Akt/Nrf2 signaling pathway.

BACKGROUND Hypoxic-Ischemic Encephalopathy (HIE) is a severe neonatal neurological disorder, in which oxidative stress serves as a central mediator of brain injury. Paeonol (Pae), a phenolic compound with established anti-inflammatory and antioxidant properties, remains underexplored as a therapeutic strategy for HIE....

Ding-Wang Hu, Jiang-Han Li, Ling-Bin Ye et al. · European Journal of Pharmaco... · 0 citations